Unknown

Dataset Information

0

High Tumor-Infiltrating Lymphocyte Count Is Associated with Distinct Gene Expression Profile and Longer Patient Survival in Advanced Ovarian Cancer.


ABSTRACT: Cancer-related immunity plays a significant role in the outcome of ovarian cancer, but the exact mechanisms are not fully explored. A retrospective, real-life observational study was conducted including 57 advanced ovarian cancer patients. Immunohistochemistry for CD4+, CD8+, and CD45+ was used for assessing tumor-infiltrating immune cells. Furthermore, an immune-related gene expression assay was performed on 12-10 samples from patients with less than and more than 1-year overall survival (OS), respectively. A higher number of CD4+ (p = 0.0028) and CD45+ (p = 0.0221) immune cells within the tumor microenvironment were associated with longer OS of patients. In a multivariate setting, higher CD4+ T cell infiltration predicted longer OS (p = 0.0392). Twenty-three differentially expressed genes-involved in antigen presentation, costimulatory signaling, matrix remodeling, metastasis formation, and myeloid cell activity-were found when comparing the prognostic groups. It was found that tumor-infiltrating immune cell counts are associated with peculiar gene expression patterns and bear prognostic information in ovarian cancer. SOX11 expression emerged and was validated as a predictive marker for OS.

SUBMITTER: Barna AJ 

PROVIDER: S-EPMC10530512 | biostudies-literature | 2023 Sep

REPOSITORIES: biostudies-literature

altmetric image

Publications

High Tumor-Infiltrating Lymphocyte Count Is Associated with Distinct Gene Expression Profile and Longer Patient Survival in Advanced Ovarian Cancer.

Barna Andras Jozsef AJ   Herold Zoltan Z   Acs Miklos M   Bazsa Sandor S   Gajdacsi Jozsef J   Garay Tamas Marton TM   Herold Magdolna M   Madaras Lilla L   Muhl Dorottya D   Nagy Akos A   Szasz Attila Marcell AM   Dank Magdolna M  

International journal of molecular sciences 20230905 18


Cancer-related immunity plays a significant role in the outcome of ovarian cancer, but the exact mechanisms are not fully explored. A retrospective, real-life observational study was conducted including 57 advanced ovarian cancer patients. Immunohistochemistry for CD4<sup>+</sup>, CD8<sup>+</sup>, and CD45<sup>+</sup> was used for assessing tumor-infiltrating immune cells. Furthermore, an immune-related gene expression assay was performed on 12-10 samples from patients with less than and more th  ...[more]

Similar Datasets

| S-EPMC5054777 | biostudies-literature
| S-EPMC2837379 | biostudies-literature
| S-EPMC6678702 | biostudies-literature
| S-EPMC4570103 | biostudies-literature
| S-EPMC10742296 | biostudies-literature
| S-EPMC10911923 | biostudies-literature
| S-EPMC4584051 | biostudies-literature
| S-EPMC8851811 | biostudies-literature
| S-EPMC10899061 | biostudies-literature
| S-ECPF-GEOD-32335 | biostudies-other